IM Cannabis Balance Sheet Health
Financial Health criteria checks 3/6
IM Cannabis has a total shareholder equity of CA$5.5M and total debt of CA$15.1M, which brings its debt-to-equity ratio to 276.4%. Its total assets and total liabilities are CA$40.2M and CA$34.7M respectively.
Key information
276.4%
Debt to equity ratio
CA$15.15m
Debt
Interest coverage ratio | n/a |
Cash | CA$700.00k |
Equity | CA$5.48m |
Total liabilities | CA$34.74m |
Total assets | CA$40.22m |
Recent financial health updates
Recent updates
IM Cannabis Shareholder Rafael Gabay raises stake
Sep 08IM Cannabis GAAP EPS of -C$0.30, revenue of C$23.8M
Aug 15IM Cannabis receives non-compliance notification from Nasdaq for minimum bid price requirement
Jul 19cbdMD And IM Cannabis Partner To Sell CBD Products In Israeli Markets
Aug 14IM Cannabis proposes public offering of securities
May 05IM Cannabis acquires Israel's largest retail and online pharmacy business from Panaxia
Apr 30Financial Position Analysis
Short Term Liabilities: IMCC's short term assets (CA$22.9M) do not cover its short term liabilities (CA$33.4M).
Long Term Liabilities: IMCC's short term assets (CA$22.9M) exceed its long term liabilities (CA$1.3M).
Debt to Equity History and Analysis
Debt Level: IMCC's net debt to equity ratio (263.6%) is considered high.
Reducing Debt: IMCC's debt to equity ratio has increased from 0% to 276.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable IMCC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: IMCC is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 5.1% per year.